• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Virtual Reality

ByteDance Employees Get VR Therapy Boost with XRHealth Partnership

by Fred Pennic 02/08/2024 Leave a Comment

XRHealth Secures $6M to Enhance Immersive VR/AR Experiences

What You Should Know: - ByteDance, the global tech giant, announced a new partnership with XRHealth, a leading healthcare platform leveraging spatial computing, to offer its employees access to VR therapy benefits. - By offering convenient, engaging, and effective VR therapy solutions, ByteDance prioritizes the well-being of its workforce, fostering a healthier and happier employee population. Immersive VR Therapy Under the partnership, ByteDance employees will gain access to
Read More

TRIPP Takes VR Meditation to New Heights on Apple Vision Pro

by Fred Pennic 02/07/2024 Leave a Comment

TRIPP Takes VR Meditation to New Heights on Apple Vision Pro

What You Should Know: - TRIPP, the award-winning wellness company, announces its arrival on the highly anticipated Apple Vision Pro, redefining the boundaries of personalized well-being experiences. - The integration with Apple Vision Pro unlocks TRIPP's most immersive and visually captivating journey yet, seamlessly blending awe-inspiring worldscapes with users' surroundings through Apple Vision Pro's groundbreaking spatial computing capabilities. Reimagining Wellness with Apple Vision
Read More

Cedars-Sinai Launches AI-Powered VR Therapy App on Apple Vision Pro

by Fred Pennic 02/02/2024 Leave a Comment

Cedars-Sinai Launches AI-Powered VR Therapy App on Apple Vision Pro

What You Should Know: - Cedars-Sinai clinicians have teamed up with AI experts to develop an AI-powered VR therapy app, Xaia, that leverages the power of Apple Vision Pro to offer an immersive, accessible approach to mental health support. - By harnessing the power of AI and virtual reality, the app offers a convenient, engaging, and effective way for individuals to manage their mental well-being. As technology continues to evolve, apps like Xaia hold immense potential to democratize
Read More

XRHealth Secures $6M to Enhance Immersive VR/AR Experiences

by Jasmine Pennic 01/09/2024 Leave a Comment

XRHealth Secures $6M to Enhance Immersive VR/AR Experiences

What You Should Know: - XRHealth, the leading healthcare platform in Spatial Computing, announced today a $6M funding round led by Asabys Partners, with participation from NOVA Prime Fund and XRHealth's existing investors. - This milestone follows the successful merger with Amelia Virtual Care, solidifying XRHealth's position as the largest extended reality (XR) platform encompassing mental, physical, and occupational health. VR/AR Meets Patient Needs XRHealth's platform leverages
Read More

VA Expands Access to Virtual Reality Pain Therapy for Veterans with AppliedVR Partnership

by Jasmine Pennic 12/20/2023 Leave a Comment

VA Expands Access to Virtual Reality Pain Therapy for Veterans with AppliedVR Partnership

What You Should Know: - The U.S. Department of Veterans Affairs (VA) is taking a major step forward in pain management by expanding its contract with AppliedVR, a provider of immersive therapeutics (ITx) using virtual reality (VR). - This contract expansion will significantly increase access to RelieVRx®, the first and only FDA-authorized in-home VR treatment for chronic lower back pain (CLBP).\ Continue Use of Virtual Reality for Treating Chronic Low Back Pain Chronic pain affects
Read More

Smileyscope Receives FDA Clearance for First-Ever VR Analgesic

by Jasmine Pennic 12/08/2023 Leave a Comment

What You Should Know: - Smileyscope™, a pioneer in virtual reality (VR) therapeutic solutions, has received Class II clearance from the U.S. Food and Drug Administration (FDA) for its Smileyscope™ Therapy system. - The FDA clearance marks Smileyscope as the first and only VR Analgesic™ available in the US. Digital Therapeutics Leadership Smileyscope's FDA clearance underscores its leadership in Digital Therapeutics, a category defined as delivering medical interventions directly to patients through evidence-based, clinically evaluated software. The Digital Therapeutics market is projected to reach 32.5 billion USD by 2030. Procedural Choreography™ Patent The FDA clearance included an evaluation of Smileyscope's patented Procedural Choreography™ technique, a proprietary method that replaces negative real-world stimuli (e.g., a needle) with positive virtual stimuli (e.g., a friendly fish). This technique enhances safety and efficacy and serves as the foundation for future therapeutic products. Clinical Trials Smileyscope's studies, the world's largest randomized trials in procedural VR, demonstrated significant reductions in child self-rated pain (up to 60%) and anxiety (up to 40%). The trials also showed benefits in caregiver distress (up to 75%) and a reduction in the use of physical restraints (up to 48%). Future Expansion Smileyscope aims to build on this success with a robust pipeline of drug-free pain and anxiety management treatments for common medical procedures across age groups. The company envisions widespread adoption in hospitals, doctor's offices, and an expanded range of patients benefiting from their drug-free treatments. "We were thrilled to receive this FDA Class II clearance. The FDA affirms Smileyscope's long-held position that we are a transformational, therapeutic VR device, raising the standard of care," said Dr. Evelyn Chan, CEO and co-founder of Smileyscope.

What You Should Know: - Smileyscope™, a pioneer in virtual reality (VR) therapeutic solutions, has received Class II clearance from the U.S. Food and Drug Administration (FDA) for its Smileyscope™ Therapy system. - The FDA clearance marks Smileyscope as the first and only VR Analgesic™ available in the US. Digital Therapeutics Leadership Smileyscope's FDA clearance underscores its leadership in Digital Therapeutics, a category defined as delivering medical interventions directly to
Read More

AppliedVR Releases Clinical Trial Results from In-Home Virtual Reality Program for Chronic Lower Back Pain

by Fred Pennic 11/08/2023 Leave a Comment

AppliedVR Releases Clinical Trial Results from In-Home Virtual Reality Program for Chronic Lower Back Pain

What You Should Know: - AppliedVR, an immersive therapeutics pioneer, conducted a large randomized controlled trial (RCT) on virtual reality (VR) therapy for treating chronic low back pain (CLBP) at home. - Results of the study were published in Mayo Clinic Proceedings: Digital Health and demonstrated that AppliedVR's RelieVRx program produced clinically meaningful improvements in adults with CLBP. - AppliedVR aims to provide a non-pharmacological and non-invasive approach to treating
Read More

XRHealth Deploys VR Headsets in Israel to Assist Victims of Hamas Attacks

by Fred Pennic 10/19/2023 Leave a Comment

XRHealth Deploys VR Headsets in Israel to Assist Victims of Hamas Attacks

What You Should Know:  - XRHealth today announced that they are currently deploying hundreds of VR headsets in Israel to treat patients coping with anxiety, stress, and PTSD as a result of the recent Hamas attacks.  - The distribution of the headsets will span across 30 hospitals, nursing homes, assisted living facilities and mental health centers throughout Israel (including three Clalit hospitals). Assisting Patients Coping with Anxiety, Stress, and PTSD Just 48-hours
Read More

Study: Virtual Reality Effective for Ketamine-Assisted Therapy

by Fred Pennic 06/19/2023 Leave a Comment

Study: Virtual Reality Effective for Ketamine-Assisted Therapy

What You Should Know:  TRIPP, a global XR wellness company, announced the completion of TRIPP PsyAssist’s Phase 1 Proof Of Concept (POC) Feasibility Study. The first phase of the breakthrough study shows virtual reality (VR) as an effective tool to help patients prepare for ketamine-assisted therapy Research Background The study focuses on investigating the effects of a Virtual Reality (VR) experience before Ketamine dosing and was conducted at the esteemed Kadima
Read More

Virtual Reality Training for Nurses Solution Launches to Enhance Nursing Education

by Fred Pennic 06/14/2023 Leave a Comment

Virtual Reality Training for Nurses Solution Launches to Enhance Nursing Education

What You Should Know:  Wolters Kluwer Health and Laerdal Medical have officially launched vrClinicals for Nursing. The virtual reality (VR) based learning solution helps address today’s gaps in nursing education and the nursing workforce, allowing students to go from the classroom to a busy hospital ward where they encounter true-to-life challenges such as prioritizing care among multiple patients and the demands of practice.vrClinicals for Nursing was designed with instructors and
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 13
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |